{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:46:24Z","timestamp":1793411184793,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T00:00:00Z","timestamp":1560038400000},"content-version":"vor","delay-in-days":159,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.nicl.2019.101895","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:28:35Z","timestamp":1560166115000},"page":"101895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum"],"prefix":"10.1016","volume":"23","author":[{"given":"Samantha L.","family":"Allison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Koscik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Jonaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B.","family":"Bendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.nicl.2019.101895_bb0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jalz.2014.03.006","article-title":"Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease","volume":"10","author":"Alexopoulos","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.nicl.2019.101895_bb0015","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2019.101895_bb0020","author":"Ashburner"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002093-200307000-00010","article-title":"Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review","volume":"17","author":"Atiya","year":"2003","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"5","key":"10.1016\/j.nicl.2019.101895_bb0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.nicl.2019.101895_bb0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neurobiolaging.2006.05.006","article-title":"CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment","volume":"28","author":"Bouwman","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/biomet\/57.3.579","article-title":"A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship","volume":"57","author":"Breslow","year":"1970","journal-title":"Biometrika"},{"key":"10.1016\/j.nicl.2019.101895_bb0045","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006310","article-title":"An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease","author":"Brickman","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0050","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2004.06.018","article-title":"A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume","volume":"23","author":"Buckner","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2019.101895_bb0055","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005291","article-title":"Age-accelerated cognitive decline in asymptomatic adults with CSF \u03b2-amyloid","author":"Clark","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1037\/0033-2909.114.3.494","article-title":"Dominance statistics: ordinal analyses to answer ordinal questions","volume":"114","author":"Cliff","year":"1993","journal-title":"Psychol. Bull."},{"issue":"12","key":"10.1016\/j.nicl.2019.101895_bb0065","doi-asserted-by":"crossref","first-page":"2322.e19","DOI":"10.1016\/j.neurobiolaging.2010.05.023","article-title":"Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification","volume":"32","author":"Davatzikos","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","article-title":"MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults","volume":"78","author":"Dickerson","year":"2012","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.nicl.2019.101895_bb0080","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","article-title":"Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults","volume":"76","author":"Dickerson","year":"2011","journal-title":"Neurology"},{"issue":"Suppl_1","key":"10.1016\/j.nicl.2019.101895_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13742-016-0147-0-o","article-title":"Wrapping FreeSurfer 6 for use in high-performance computing environments","volume":"5","author":"Ellis","year":"2016","journal-title":"Gigascience"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid A\u03b242 correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.nicl.2019.101895_bb0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1037\/h0031619","article-title":"Measuring nominal scale agreement among many raters","volume":"76","author":"Fleiss","year":"1971","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.nicl.2019.101895_bb0110","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"2013"},{"issue":"9170","key":"10.1016\/j.nicl.2019.101895_bb0115","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(99)00496-1","article-title":"Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease","volume":"353","author":"Fox","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2019.101895_bb0125","first-page":"743","article-title":"PC VIPR: a high-speed 3D phase-contrast method for flow quantification and high-resolution angiography","volume":"26","author":"Gu","year":"2005","journal-title":"Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.42.1.183","article-title":"MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease","volume":"42","author":"Jack","year":"1992","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nicl.2019.101895_bb0145","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/brain\/awv283","article-title":"Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings","volume":"138","author":"Jack","year":"2015","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nicl.2019.101895_bb0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nicl.2019.101895_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.nicl.2019.101895_bb0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.nicl.2019.101895_bb0165","first-page":"130","article-title":"The Wisconsin registry for Alzheimer's prevention: a review of findings and current directions","volume":"10","author":"Johnson","year":"2018","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann. Math. Stat."},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0180","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/01.STR.25.2.318","article-title":"Magnetic resonance abnormalities and cardiovascular disease in older adults. The cardiovascular health study","volume":"25","author":"Manolio","year":"1994","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.nicl.2019.101895_bb0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.81","article-title":"Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease","volume":"1","author":"Mattsson","year":"2014","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia: The Journal of the Alzheimer's Association"},{"issue":"14","key":"10.1016\/j.nicl.2019.101895_bb0195","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1212\/WNL.0000000000005261","article-title":"Clinical value of neurofilament and phospho-tau\/tau ratio in the frontotemporal dementia spectrum","volume":"90","author":"Meeter","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nicl.2019.101895_bb0200","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nicl.2019.101895_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pscychresns.2011.01.007","article-title":"Statistical adjustments for brain size in volumetric neuroimaging studies: some practical implications in methods","volume":"193","author":"O'Brien","year":"2011","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.nicl.2019.101895_bb0210","series-title":"Biomedical Imaging: From Nano to Macro, 2008. ISBI 2008. 5th IEEE International Symposium","article-title":"Cortical correspondence using entropy-based particle systems and local features","volume":"vols. 1637-1640","author":"Oguz","year":"2008"},{"issue":"7","key":"10.1016\/j.nicl.2019.101895_bb0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \"preclinical\" Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2019.101895_bb0235","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nicl.2019.101895_bb0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cercor\/7.3.268","article-title":"Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter","volume":"7","author":"Raz","year":"1997","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroimage.2009.06.074","article-title":"Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast","volume":"48","author":"Salat","year":"2009","journal-title":"NeuroImage"},{"issue":"7","key":"10.1016\/j.nicl.2019.101895_bb0250","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","article-title":"Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI","volume":"99","author":"Scahill","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.nicl.2019.101895_bb0255","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A\u03b21-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2019.101895_bb0260","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","article-title":"A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity","volume":"11","author":"Schwarz","year":"2016","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.nicl.2019.101895_bb0265","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","article-title":"Tau and A\u03b242 in cerebrospinal fluid from healthy adults 21\u201393 years of age: establishment of reference values","volume":"47","author":"Sj\u00f6gren","year":"2001","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.nicl.2019.101895_bb0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish mortality registry","volume":"71","author":"Skillb\u00e4ck","year":"2014","journal-title":"JAMA Neurology"},{"issue":"12","key":"10.1016\/j.nicl.2019.101895_bb0275","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1007\/s00330-009-1512-5","article-title":"Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease","volume":"19","author":"Sluimer","year":"2009","journal-title":"Eur. Radiol."},{"issue":"14","key":"10.1016\/j.nicl.2019.101895_bb0280","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","article-title":"ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes","volume":"92","author":"Soldan","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nicl.2019.101895_bb0285","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-\u03b2 peptide deposition identified with Pittsburgh compound B: cognitive decline associated with A\u03b2 deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2051-5960-2-26","article-title":"Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition","volume":"2","author":"Toledo","year":"2014","journal-title":"Acta Neuropathologica Communications"},{"issue":"12","key":"10.1016\/j.nicl.2019.101895_bb0295","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jamaneurol.2017.2712","article-title":"Interpreting biomarker results in individual patients with mild cognitive impairment in the Alzheimer's biomarkers in daily practice (ABIDE) project","volume":"74","author":"van Maurik","year":"2017","journal-title":"JAMA Neurology"},{"issue":"17","key":"10.1016\/j.nicl.2019.101895_bb0300","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/WNL.0b013e3182704056","article-title":"Injury markers predict time to dementia in subjects with MCI and amyloid pathology","volume":"79","author":"van Rossum","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nicl.2019.101895_bb0305","article-title":"LUMIPULSE\u00ae G total tau: key performances of a fully automated chemiluminescent immunoassay","volume":"13","author":"Vandijck","year":"2017","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.1016\/j.nicl.2019.101895_bb0310","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2019.101895_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","article-title":"NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers","volume":"44","author":"Vos","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nicl.2019.101895_bb0320","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.neuroimage.2009.05.084","article-title":"Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray\/white contrast: a multi-sample MRI study","volume":"47","author":"Westlye","year":"2009","journal-title":"NeuroImage"},{"issue":"21","key":"10.1016\/j.nicl.2019.101895_bb0325","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nicl.2019.101895_bb0335","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurology"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219302451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219302451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:22:25Z","timestamp":1761970945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158219302451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":67,"alternative-id":["S2213158219302451"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101895","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101895"}}